Literature DB >> 20665482

Long-term results of surgery for lithium-associated hyperparathyroidism.

J Järhult1, S Ander, B Asking, S Jansson, A Meehan, A Kristoffersson, J Nordenström.   

Abstract

BACKGROUND: Lithium therapy for affective bipolar disease is frequently associated with hyperparathyroidism (HPT), but the results of surgical treatment are virtually unknown. The aim of this retrospective review was to analyse the long-term outcome after surgery for lithium-induced HPT in a large series of patients.
METHODS: Seventy-one patients on chronic lithium therapy who underwent surgery in three university and three district hospitals in Sweden were followed for a median of 6.3 years. Histopathology, complications of surgery and normocalcaemia at 6 months after surgery and last follow-up were analysed.
RESULTS: The primary histopathological diagnoses were adenoma (45 per cent), double adenomas (3 per cent) and hyperplasia (52 per cent). No permanent paresis of the recurrent laryngeal nerve was recorded but 13 per cent of the patients suffered from permanent hypoparathyroidism. At follow-up, the rate of persistent and recurrent HPT was 42 per cent regardless of the histopathological diagnosis.
CONCLUSION: The results of conventional surgery for lithium-associated HPT are poor. The surgical approach should be adjusted for the multiglandular disease that is usually the cause of HPT in patients on chronic lithium therapy.
Copyright © 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665482     DOI: 10.1002/bjs.7199

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  Lithium-associated hyperparathyroidism: surgical strategies in the era of minimally invasive parathyroidectomy.

Authors:  Anita R Skandarajah; F Fausto Palazzo; Jean-François Henry
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

2.  The Weight of the Resected Gland Predicts Rate of Success After Image-Guided Focused Parathyroidectomy.

Authors:  Olov Norlén; Anthony Glover; Nisar Zaidi; Adam Aniss; Mark Sywak; Stan Sidhu; Leigh Delbridge
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

3.  Relation of hyperparathyroidism and hypercalcemia to bipolar and psychotic disorders.

Authors:  Chioma O Enyi; Brendan D'Souza; Linda Barloon; Onyedika J Ilonze; Ranjit Chacko
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-04-08

4.  Hypercalcemia in patients with bipolar disorder treated with lithium: a cross-sectional study.

Authors:  Bas A Twigt; Bernard M Houweling; Menno R Vriens; Eline J Regeer; Ralph W Kupka; Inne Hm Borel Rinkes; Gerlof D Valk
Journal:  Int J Bipolar Disord       Date:  2013-09-16

5.  Lithium-induced Symptomatic Hypercalcemia and Hyperparathyroidism in a Patient with Bipolar Affective Disorder: A Case Report and Review of Literature.

Authors:  Gnanaselvam Pamathy; Umesh Jayarajah; Tshering Wangmo; Anura S K Banagala
Journal:  Indian J Psychol Med       Date:  2018 Jul-Aug

6.  Three Patients with Lithium-Associated Hyperparathyroidism: Literature Review Regarding Medical and Surgical Management.

Authors:  Ramy M Hanna; Huma Hasnain; Michelle D Sangalang; Jennifer Han; Aarthi Arasu; Farid Arman; Marina Barsoum; Hyunah Poa; Anjay Rastogi; Avital Harari
Journal:  Case Rep Nephrol Dial       Date:  2019-08-20

Review 7.  The Role of Lithium in Management of Endocrine Tumors-A Comprehensive Review.

Authors:  Shilpa Thakur; Andrew Tobey; Joanna Klubo-Gwiezdzinska
Journal:  Front Oncol       Date:  2019-10-18       Impact factor: 6.244

Review 8.  Sporadic multiple parathyroid gland disease--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Marcin Barczyński; Robert Bränström; Gianlorenzo Dionigi; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2015-11-05       Impact factor: 3.445

9.  Lithium-Associated Hypercalcemia: Pathophysiology, Prevalence, Management.

Authors:  Adrian D Meehan; Ruzan Udumyan; Mathias Kardell; Mikael Landén; Johannes Järhult; Göran Wallin
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.